pancreatic cancer

Peer-Reviewed Publication University of Illinois Chicago image: UIC researchers are using microfluidics to make advancements in pancreatic cancer treatment. view more   Credit: (Photo: Sana Sheybanikashani) Pinned between the stomach and spine, the pancreas supervises both digestion and blood sugar in the body. It’s also the site of an aggressive cancer called pancreatic ductal adenocarcinoma, or PDAC. PDAC is […]

by Johns Hopkins University School of Medicine edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes The image shows an ultrasound endoscope in the stomach imaging the pancreas (left picture) and corresponding small pancreatic cancer that is undergoing fine needle biopsy under endoscopic ultrasound (EUS) guidance. EUS is one of the main tools used for surveillance of

by Northwestern University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Study first author Pratima Saini in Abdel-Mohsen’s lab at Northwestern University Feinberg School of Medicine in Chicago. Credit: Northwestern University Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance:

by University of Skövde edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: Unsplash/CC0 Public Domain Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world’s deadliest cancers. A heart medicine first prescribed in the 18th century is now being tested as a potential treatment for pancreatic cancer—one of the most aggressive and

by NYU Langone Health edited by Sadie Harley, reviewed by Robert Egan   Credit: Unsplash/CC0 Public Domain Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.

  Megan Brooks August 21, 2025 A novel cancer vaccine that stimulates T-cell activity in KRAS-driven pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC) has shown promise in early testing. The investigational vaccine, ELI-002, developed by Elicio Therapeutics, is designed to train the immune system to recognize and attack tumor cells harboring mutant KRAS, which is present in

by Justin Stebbing, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin Stevia rebaudiana. Credit: public domain In an unexpected twist in the fight against cancer, humble kitchen bacteria and a plant best known for sweetening tea could one day help in treating one of humanity’s deadliest diseases, new research suggests. A group of scientists in Japan has discovered

by University of California – San Diego edited by Sadie Harley, reviewed by Andrew Zinin On the left are pancreas cells showing early stages of malignant cancer in brown. On the right, the same cells stained blue indicate they are Integrin β3 (ITGB3) positive. Credit: UC San Diego Health Sciences Precancerous cells must adapt to and overcome cellular